raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:732

Polymyositis

Type
Disease
Group
Disorder
Inheritance
Not applicable
Age of onset
Adult, Elderly
Status
active

A rare idiopathic inflammatory myopathy (IIM) historically characterized by symmetric proximal muscle weakness, elevated muscle enzymes (creatine kinase), myopathic findings on electromyography, and muscle biopsy showing endomyial infiltration composed mainly of macrophages and lymphocytes. The features are non-specific, thus the disease should be distinguished from similar entities with specific clinical, immunological, histological features, notably dermatomyositis, immune-mediated necrotizing myopathy, anti-synthetase syndrome, inclusion body myositis, and myositis associated with other connective tissue disorder.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enPolymyositis
frPolymyosite
dePolymyositis
esPolimiositis
itPolimiositePM
nlPolymyositis
ptPolimiosite
plZapalenie wielomięśniowePM
csPolymyozitidaPM
ukПоліміозит
zh多发性肌炎
trPolimiyozit

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10M33.2Especificvalidated
ICD-114A41.1Especificvalidated
MONDO0019127Evalidated
MeSHD017285Evalidated
UMLSC0085655Evalidated
GARD7425Evalidated
MedDRA10036102Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

8 records
TypeClassValueAreaQualificationValidationSource
Annual incidence1-9 / 1 000 0000.585 / 100 000EuropeValue and classValidatedORPHANET
Point prevalence1-9 / 100 0007.1 / 100 000EuropeValue and classValidated[EXPERT]
Annual incidence1-9 / 1 000 0000.75 / 100 000ArgentinaValue and classValidated23965482[PMID]
Point prevalence1-9 / 100 0007.2 / 100 000ArgentinaValue and classValidated23965482[PMID]
Annual incidence1-9 / 1 000 0000.41 / 100 000AustraliaValue and classValidated23981756[PMID]
Point prevalence1-9 / 100 0007.2 / 100 000AustraliaValue and classValidated23981756[PMID]
Annual incidence1-9 / 1 000 0000.39 / 100 000SpainValue and classValidated18053482[PMID]
Annual incidence1-9 / 1 000 0000.76 / 100 000SwedenValue and classValidated9137324[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

60 annotations · validated 2024-06-27
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0004303Abnormal muscle fiber morphology
HP:0002829Arthralgia
HP:0002960Autoimmunity
HP:0012735Cough
HP:0003457EMG abnormality
HP:0012544Elevated circulating aldolase concentration
HP:0003236Elevated circulating creatine kinase concentration
HP:0001252Hypotonia
HP:0003701Proximal muscle weakness
Frequent (79-30%)
HP:0006530Abnormal pulmonary interstitial morphology
HP:0002039Anorexia
HP:0034145Anti-alanyl-tRNA synthetase antibody positivity
HP:0034147Anti-aminoacyl-tRNA synthetase antibody positivity
HP:0034151Anti-asparaginyl-tRNA synthetase antibody positivity
HP:0034146Anti-glycyl tRNA-synthetase antibody positivity
HP:0034152Anti-histidyl tRNA synthetase antibody positivity
HP:0034148Anti-isoleucyl tRNA-synthetase antibody positivity
HP:0034149Anti-phenylalanyl tRNA synthetase antibody positivity
HP:0033713Anti-signal recognition particle antibody positivity
HP:0034143Anti-threonyl-tRNA synthetase antibody positivity
HP:0034150Anti-tyrosyl-tRNA synthetase antibody positivity
HP:0003493Antinuclear antibody positivity
HP:0001369Arthritis
HP:0002019Constipation
HP:0002875Exertional dyspnea
HP:0012378Fatigue
HP:0001945Fever
HP:0003326Myalgia
HP:0002093Respiratory insufficiency
HP:0001824Weight loss
Occasional (29-5%)
HP:0002027Abdominal pain
HP:0005150Abnormal atrioventricular conduction
HP:0001633Abnormal mitral valve morphology
HP:0000091Abnormal renal tubule morphology
HP:0001608Abnormality of the voice
HP:0011675Arrhythmia
HP:0100595Camptocormia
HP:0031352Chest tightness
HP:0000934Chondrocalcinosis
HP:0001635Congestive heart failure
HP:0001644Dilated cardiomyopathy
HP:0001618Dysphonia
HP:0003565Elevated erythrocyte sedimentation rate
HP:0001288Gait disturbance
HP:0002020Gastroesophageal reflux
HP:0002239Gastrointestinal hemorrhage
HP:0002240Hepatomegaly
HP:0001611Hypernasal speech
HP:0001639Hypertrophic cardiomyopathy
HP:0100827Lymphocytosis
HP:0001658Myocardial infarction
HP:0002068Neuromuscular dysphagia
HP:0001701Pericarditis
HP:0002206Pulmonary fibrosis
HP:0030880Raynaud phenomenon
HP:0001315Reduced tendon reflexes
HP:0000988Skin rash
HP:0001894Thrombocytosis
HP:0002633Vasculitis
HP:0004936Venous thrombosis

Run the differential on the 9 obligate / very frequent terms

Annotation source: 33085276[PMID]_37329941[PMID]_36556960[PMID]_29632291[PMID]

7

Sources for this card